XML 131 R40.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation and Other Benefit Plans (Tables)
 12 Months Ended
Apr. 03, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Restricted Stock Units Activities
RSUs
(In millions, except per share and year data)
Number of
Shares
 
Weighted-
Average
Grant Date Fair Value
Outstanding and unvested at March 29, 2019
21

 
$
23.36

Granted
13

 
$
19.65

Vested
(15
)
 
$
22.38

Forfeited
(12
)
 
$
21.90

Outstanding and unvested at April 3, 2020
7

 
$
21.33
Schedule of PRUs Activity
PRUs
(In millions, except per share and year data)
Number of
Shares
 
Weighted-
Average
Grant Date Fair Value
Outstanding and unvested at March 29, 2019
2

 
$
27.04

Granted
3

 
$
21.69

Vested (1)
—

 
$
28.25

Canceled
(1
)
 
$
21.46

Forfeited
(2
)
 
$
23.81

Unvested at April 3, 2020
2

 
$
22.68

Vested and unreleased at April 3, 2020 (1)
—

 


Outstanding at April 3, 2020
2

 
 
 

(1) The number of shares is less than 1 million.
Schedule Of PRUs Valuation Assumptions The valuation and the underlying weighted-average assumptions for PRUs are summarized below:
 
Year Ended
 
April 3, 2020
 
March 29, 2019
 
March 30, 2018
Expected term
1.9 years

 
2.7 years

 
2.8 years

Expected volatility
38.1
%
 
34.2
%
 
23.2
%
Risk-free interest rate
1.7
%
 
2.7
%
 
1.5
%
Expected dividend yield
1.1
%
 
—
%
 
—
%
Weighted-average grant date fair value of PRUs
$
21.69

 
$
21.30

 
$
32.78
Schedule of Stock Option Activities
Stock options
(In millions, except per share and year data)
Number of
Shares
 
Weighted-
Average
Exercise Price (1)
 
Weighted-
Average
Remaining Contractual Term
(Years)
 
Aggregate Intrinsic
Value
Outstanding at March 29, 2019
12

 
$
7.83

 
 
 
 
Granted
3

 
$
19.85

 
 
 
 
Exercised
(11
)
 
$
7.30

 
 
 
 
Canceled
(1
)
 
$
19.85

 
 
 
 
Forfeited and expired
(1
)
 
$
4.42

 
 
 
 
Outstanding at April 3, 2020
2

 
$
6.85

 
 
 
 
Exercisable at April 3, 2020
1

 
$
5.30

 
4.0
 
$
9

 
(1) As a result of our special dividend of $12 per share paid in January 2020, we reduced the exercise price of 2 million options to the extent that their original exercise price equaled or exceeded $12. The weighted-average exercise prices in the table reflects the exercise price as of the date of the activity and the exercise price of outstanding and exercisable awards as of April 3, 2020 reflect the adjusted exercise prices.
Schedule of ESPP Activities
The following table summarizes activity related to the purchase rights issued under the ESPP:
 
Year Ended
(In millions)
April 3, 2020
 
March 29, 2019
 
March 30, 2018
Shares issued under the ESPP
2

 
—

 
3

Proceeds from issuance of shares
$
39

 
$
—

 
$
69
Schedule of Stock-based Compensation Expense
Total stock-based compensation expense and the related income tax benefit recognized for all of our equity incentive plans in our Consolidated Statements of Operations were as follows:
 
Year Ended
(In millions)
April 3, 2020
 
March 29, 2019
 
March 30, 2018
Cost of revenues
$
2

 
$
6

 
$
14

Sales and marketing
29

 
42

 
62

Research and development
30

 
34

 
64

General and administrative
58

 
76

 
161

Restructuring, transition and other costs
20

 
—

 
—

Other income (expense), net
1

 
—

 
—

Total stock-based compensation from continuing operations
140

 
158

 
301

Discontinued operations
172

 
194

 
$
309

Total stock-based compensation expense
$
312

 
$
352

 
$
610

Income tax benefit for stock-based compensation expense
$
(55
)
 
$
(73
)
 
$
(116
)
Schedule of Employer 401K Contributions Our employer matching contributions to the 401(k) plan were as follows, including contributions to employees of our discontinued operations:
 
Year Ended
(In millions)
April 3, 2020
 
March 29, 2019
 
March 30, 2018
401(k) matching contributions
$
16

 
$
23

 
$
25